TLDR Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.
The review article discusses the potential and challenges of using cell therapy for treating severe psoriasis, especially in patients unresponsive to biologic therapies. Mesenchymal stem cells (MSCs) and haematopoietic stem cell transplantation (HSCT) offer immunomodulatory and anti-inflammatory benefits, but come with significant risks, costs, and regulatory challenges. MSCs and T regulatory cells (Tregs) are highlighted as potentially safer options compared to HSCT. The article emphasizes the need for well-designed, controlled trials to evaluate the efficacy and safety of these therapies. Early trials show promise, but larger studies are necessary to confirm their effectiveness and address clinical application challenges.
320 citations
,
December 2018 in “Frontiers in Immunology” Changing how mesenchymal stromal cells are grown can improve their healing abilities.
418 citations
,
January 2018 in “Journal of Investigative Dermatology” Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.
Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.
August 2024 in “Indian Journal of Skin Allergy” Stem-cell therapy shows promise for skin conditions but needs more research.
489 citations
,
November 2021 in “Signal Transduction and Targeted Therapy” The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.
2 citations
,
October 2015 in “Human Gene Therapy” The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.
November 2025 in “International Journal of Molecular Sciences” PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.